×

Biogen Surges on Promising Alzheimer's Drug Assessment

Published Nov 04 2020 at 6:14 PM GMT
Key
Points
  • The biotech giant received a big boost after US Food and Drug Administration regulators appeared to give a positive assessment of the company's experimental Alzheimer's disease drug, sending shares up 40%.




Trending

Stats

  • Published Nov 4, 2020 6:14 PM GMT